Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Safety Analyses From the Randomized, Placebo-Controlled, Phase 3 TALAPRO-2 Study - Talazoparib + Enzalutamide in mCRPC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Arun Azad
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Arun Azad
223 views
June 20, 2023
Comments 0
Login to view comments.
Click here to Login
GU